Skip Navigation


JAC Advance Access originally published online on March 31, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/5/860    most recent
dkh198v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Johnson, A. P.
Right arrow Articles by Livermore, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, A. P.
Right arrow Articles by Livermore, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2004) 53, 860-862
© 2004 The British Society for Antimicrobial Chemotherapy

Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar

Alan P. Johnson*, Shazad Mushtaq, Marina Warner and David M. Livermore

Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, Specialist and Reference Microbiology Division, Colindale, London NW9 5HT, UK

Received 27 January 2004; returned 12 February 2004; revised 16 February 2004; accepted 17 February 2004

Objective: Iso-Sensitest agar (ISA), which is recommended by the BSAC for routine susceptibility testing of staphylococci and enterococci, contains insufficient calcium for testing daptomycin. Isotonic agar supplemented with 50 mg/L calcium has been advocated, but is not routinely available in many laboratories. We evaluated a daptomycin Etest that incorporates a constant level of calcium throughout the daptomycin gradient, designed to give an appropriate concentration around the strip during testing, as an alternative for susceptibility testing on ISA.

Methods: Ninety-one isolates of Staphylococcus aureus (45 methicillin-susceptible, 46 methicillin-resistant) and 90 enterococci (47 Enterococcus faecalis, 43 Enterococcus faecium) were tested. Daptomycin Etest MICs were determined on ISA, whereas agar dilution MICs were determined in parallel on Isotonic agar supplemented with calcium to 50 mg/L as a control.

Results: The agar dilution and Etest MIC ranges of daptomycin for S. aureus were 0.25–1 mg/L (mode 0.5 mg/L), and 0.125–2 mg/L (mode 0.25 mg/L), respectively. The corresponding MIC values for enterococci were 0.25–4 mg/L (mode, 1 mg/L) and 0.125–4 mg/L (mode, 2 mg/L). For staphylococci, 86% of the Etest MIC results were within one dilution of the agar dilution values, and for enterococci, 90% of the Etest MIC results met these criteria. When results from the two methods were not identical, there was a tendency for the Etest MIC values to be lower than the agar dilution values.

Conclusions: This study shows that calcium-supplemented daptomycin Etests on ISA are an accurate and convenient alternative to calcium-supplemented Isotonic agar.

Keywords: lipopeptides, enterococci, Staphylococcus aureus, MRSA

* Corresponding author. Present address: Division of Healthcare-Associated Infection and Antimicrobial Resistance, Communicable Disease Surveillance Centre, Colindale, London NW9 5EQ, UK. Tel: +44-20-8200-6868, ext. 3043; Fax: +44-20-8205-9185; E-mail: Alan.Johnson{at}hpa.org.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
L. A. Jevitt, G. M. Thorne, M. M. Traczewski, R. N. Jones, J. E. McGowan Jr., F. C. Tenover, and S. D. Brown
Multicenter Evaluation of the Etest and Disk Diffusion Methods for Differentiating Daptomycin-Susceptible from Non-Daptomycin-Susceptible Staphylococcus aureus Isolates.
J. Clin. Microbiol., September 1, 2006; 44(9): 3098 - 3104.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
M. R Green, C. Anasetti, R. L Sandin, N. E Rolfe, and J. N Greene
Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans
Journal of Oncology Pharmacy Practice, September 1, 2006; 12(3): 179 - 181.
[Abstract] [PDF]


Home page
J. Clin. Microbiol.Home page
J. H. Jorgensen and S. A. Crawford
Assessment of Two Commercial Susceptibility Test Methods for Determination of Daptomycin MICs.
J. Clin. Microbiol., June 1, 2006; 44(6): 2126 - 2129.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.